Home treatment for cancer patients using their own stem cells
Official title: Home-based Autologous Hematopoietic Stem Cell Transplantation to ImproveOutcomes and Decrease Costs
Funded at University of Kansas Medical Center · NIH-11251676 · Data updated 2026-11-12
This study is exploring a new way for older cancer patients to get stem cell treatment at home instead of in a hospital, with daily visits from healthcare providers to offer personalized support and make the experience easier for both patients and their caregivers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | June 1, 2020 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $439,660 |
| NIH project number | 7R01AG066719-05 |
| Project ID | NIH-11251676 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older cancer patients who are eligible for autologous hematopoietic stem cell transplantation.
✕Less likely to help
Patients who are not undergoing autologous hematopoietic stem cell transplantation or those who require intensive hospital-based care may not benefit from this research.
What this research studies
This research investigates a new approach to autologous hematopoietic stem cell transplantation (HCT) that allows older cancer patients to receive treatment at home instead of in a hospital. By providing intensive support and individualized care management, the study aims to help patients and their caregivers manage the complexities of HCT in a more comfortable environment. The approach includes daily house calls from healthcare providers who work closely with patients and caregivers to create tailored treatment plans, potentially improving quality of life and reducing caregiver strain.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality of life for cancer patients and their caregivers while reducing healthcare costs.
How similar studies have gone: Previous pilot studies have shown promising results for home-based HCT, indicating that this approach may be effective and beneficial for patients.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Sung, Anthony — University of Kansas Medical Center
- Study coordinator: Sung, Anthony
Related research
Other NIH-funded projects on the same topics.
-
Gentle electrical stimulation to keep muscles strong during stem cell transplant
This project uses small, gentle electrical pulses to try to help Veterans keep muscle strength and reduce fatigue during and after stem cell transplants for blood cancers.
-
Inpatient yoga therapy for cancer patients undergoing stem cell transplant
A randomized trial will test whether an inpatient yoga program helps people receiving stem cell transplants feel better and cope with treatment.
-
A structured peer support program for people having stem cell transplants
A brief, supportive, phone-based peer program for adults with blood cancers undergoing stem cell transplant to help manage stress and improve recovery.
-
T Cell Precursors to Restore Immune Power After Stem Cell Transplants
This grant supports a patient-friendly approach to speed up immune recovery after a stem cell transplant by giving patients donor‑made T cell precursors that mature into healthy immune cells.
-
Engineering patient avatars to study GVHD after bone marrow transplant
Researchers are creating patient-specific lab models of the gut, liver, and blood to better understand and prevent GVHD after bone marrow transplant, with a focus on children.
-
Optimizing stem cell transplants to treat non-malignant blood diseases
A researcher is pursuing a five-year plan to improve stem cell transplantation strategies for non-cancer blood illnesses, with a focus on safer conditioning, better stem cell collection, and gene editing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.